NCT00497926View on ClinicalTrials.gov

Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion

PHASE2TerminatedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

March 31, 2023

Study Completion Date

April 30, 2023

Conditions

Kidney Failure

Interventions

BIOLOGICAL

Enriched Hematopoietic Stem Cell Infusion

Enriched Hematopoietic Stem Cell Infusion

Trial Locations (2)

27710

Duke University, Durham

60611

Northwestern Memorial Hospital, Chicago

Sponsors

Collaborators (1)

Duke University

All Listed Sponsors

collaborator

Northwestern University

OTHER

collaborator

Regenerex, LLC

UNKNOWN

collaborator

Duke University

OTHER

lead

Talaris Therapeutics Inc.

INDUSTRY